Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy.

MLA

Ho, Jennifer E., et al. “Biomarkers of Cardiovascular Stress and Fibrosis in Preclinical Hypertrophic Cardiomyopathy.” Open Heart, vol. 4, no. 2, Nov. 2017, p. e000615. EBSCOhost, https://doi.org/10.1136/openhrt-2017-000615.

APA

Ho, J. E., Shi, L., Day, S. M., Colan, S. D., Russell, M. W., Towbin, J. A., Sherrid, M. V., Canter, C. E., Jefferies, J. L., Murphy, A., Taylor, M., Mestroni, L., Cirino, A. L., Sleeper, L. A., Jarolim, P., Lopez, B., Gonzalez, A., Diez, J., Orav, E. J., & Ho, C. Y. (2017). Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy. Open Heart, 4(2), e000615. https://doi.org/10.1136/openhrt-2017-000615

Chicago

Ho, Jennifer E, Ling Shi, Sharlene M Day, Steven D Colan, Mark W Russell, Jeffrey A Towbin, Mark V Sherrid, et al. 2017. “Biomarkers of Cardiovascular Stress and Fibrosis in Preclinical Hypertrophic Cardiomyopathy.” Open Heart 4 (2): e000615. doi:10.1136/openhrt-2017-000615.